author_facet Ooi, Poh Hwa
Hager, Amber
Mazurak, Vera C.
Dajani, Khaled
Bhargava, Ravi
Gilmour, Susan M.
Mager, Diana R.
Ooi, Poh Hwa
Hager, Amber
Mazurak, Vera C.
Dajani, Khaled
Bhargava, Ravi
Gilmour, Susan M.
Mager, Diana R.
author Ooi, Poh Hwa
Hager, Amber
Mazurak, Vera C.
Dajani, Khaled
Bhargava, Ravi
Gilmour, Susan M.
Mager, Diana R.
spellingShingle Ooi, Poh Hwa
Hager, Amber
Mazurak, Vera C.
Dajani, Khaled
Bhargava, Ravi
Gilmour, Susan M.
Mager, Diana R.
Liver Transplantation
Sarcopenia in Chronic Liver Disease: Impact on Outcomes
Transplantation
Hepatology
Surgery
author_sort ooi, poh hwa
spelling Ooi, Poh Hwa Hager, Amber Mazurak, Vera C. Dajani, Khaled Bhargava, Ravi Gilmour, Susan M. Mager, Diana R. 1527-6465 1527-6473 Ovid Technologies (Wolters Kluwer Health) Transplantation Hepatology Surgery http://dx.doi.org/10.1002/lt.25591 <jats:p>Malnutrition is a common complication in patients with end‐stage liver disease (ESLD) awaiting liver transplantation (LT). Malnutrition and sarcopenia overlap in etiology and outcomes, with sarcopenia being defined as reduced skeletal muscle mass and muscle function. The purpose of this review was to identify the prevalence of sarcopenia with and without obesity in adults and children with ESLD and to assess the methodological considerations in sarcopenia diagnosis and the association of sarcopenia with pre‐ and post‐LT outcomes. A total of 38 articles (35 adult and 3 pediatric articles) retrieved from PubMed or Web of Science databases were included. In adults, the prevalence rates of pre‐LT sarcopenia, pre‐LT sarcopenic obesity (SO), post‐LT sarcopenia, and post‐LT SO were 14%‐78%, 2%‐42%, 30%‐100%, and 88%, respectively. Only 2 adult studies assessed muscle function in patients diagnosed with sarcopenia. The presence of pre‐LT sarcopenia is associated with higher wait‐list mortality, greater postoperative mortality, higher infection risk and postoperative complications, longer intensive care unit (ICU) stay, and ventilator dependency. The emerging pediatric data suggest that sarcopenia is prevalent in pre‐ and post‐LT periods. In 1 pediatric study, sarcopenia was associated with poor growth, longer perioperative length of stay (total/ICU) and ventilator dependency, and increased rehospitalization in children after LT. In conclusion, there is a high prevalence of sarcopenia in adults and children with ESLD. Sarcopenia is associated with adverse clinical outcomes. The present review is limited by heterogeneity in the definition of sarcopenia and in the methodological approaches in assessing sarcopenia. Future studies are needed to standardize the sarcopenia diagnosis and muscle function assessment, particularly in the pediatric population, to enable early identification and treatment of sarcopenia in adults and children with ESLD.</jats:p> Sarcopenia in Chronic Liver Disease: Impact on Outcomes Liver Transplantation
doi_str_mv 10.1002/lt.25591
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9sdC4yNTU5MQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9sdC4yNTU5MQ
institution DE-14
DE-105
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Zi4
DE-Gla1
DE-15
DE-Pl11
DE-Rs1
imprint Ovid Technologies (Wolters Kluwer Health), 2019
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2019
issn 1527-6473
1527-6465
issn_str_mv 1527-6473
1527-6465
language English
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
match_str ooi2019sarcopeniainchronicliverdiseaseimpactonoutcomes
publishDateSort 2019
publisher Ovid Technologies (Wolters Kluwer Health)
recordtype ai
record_format ai
series Liver Transplantation
source_id 49
title Sarcopenia in Chronic Liver Disease: Impact on Outcomes
title_unstemmed Sarcopenia in Chronic Liver Disease: Impact on Outcomes
title_full Sarcopenia in Chronic Liver Disease: Impact on Outcomes
title_fullStr Sarcopenia in Chronic Liver Disease: Impact on Outcomes
title_full_unstemmed Sarcopenia in Chronic Liver Disease: Impact on Outcomes
title_short Sarcopenia in Chronic Liver Disease: Impact on Outcomes
title_sort sarcopenia in chronic liver disease: impact on outcomes
topic Transplantation
Hepatology
Surgery
url http://dx.doi.org/10.1002/lt.25591
publishDate 2019
physical 1422-1438
description <jats:p>Malnutrition is a common complication in patients with end‐stage liver disease (ESLD) awaiting liver transplantation (LT). Malnutrition and sarcopenia overlap in etiology and outcomes, with sarcopenia being defined as reduced skeletal muscle mass and muscle function. The purpose of this review was to identify the prevalence of sarcopenia with and without obesity in adults and children with ESLD and to assess the methodological considerations in sarcopenia diagnosis and the association of sarcopenia with pre‐ and post‐LT outcomes. A total of 38 articles (35 adult and 3 pediatric articles) retrieved from PubMed or Web of Science databases were included. In adults, the prevalence rates of pre‐LT sarcopenia, pre‐LT sarcopenic obesity (SO), post‐LT sarcopenia, and post‐LT SO were 14%‐78%, 2%‐42%, 30%‐100%, and 88%, respectively. Only 2 adult studies assessed muscle function in patients diagnosed with sarcopenia. The presence of pre‐LT sarcopenia is associated with higher wait‐list mortality, greater postoperative mortality, higher infection risk and postoperative complications, longer intensive care unit (ICU) stay, and ventilator dependency. The emerging pediatric data suggest that sarcopenia is prevalent in pre‐ and post‐LT periods. In 1 pediatric study, sarcopenia was associated with poor growth, longer perioperative length of stay (total/ICU) and ventilator dependency, and increased rehospitalization in children after LT. In conclusion, there is a high prevalence of sarcopenia in adults and children with ESLD. Sarcopenia is associated with adverse clinical outcomes. The present review is limited by heterogeneity in the definition of sarcopenia and in the methodological approaches in assessing sarcopenia. Future studies are needed to standardize the sarcopenia diagnosis and muscle function assessment, particularly in the pediatric population, to enable early identification and treatment of sarcopenia in adults and children with ESLD.</jats:p>
container_issue 9
container_start_page 1422
container_title Liver Transplantation
container_volume 25
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792347801276907523
geogr_code not assigned
last_indexed 2024-03-01T18:01:00.455Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Sarcopenia+in+Chronic+Liver+Disease%3A+Impact+on+Outcomes&rft.date=2019-09-01&genre=article&issn=1527-6473&volume=25&issue=9&spage=1422&epage=1438&pages=1422-1438&jtitle=Liver+Transplantation&atitle=Sarcopenia+in+Chronic+Liver+Disease%3A+Impact+on+Outcomes&aulast=Mager&aufirst=Diana+R.&rft_id=info%3Adoi%2F10.1002%2Flt.25591&rft.language%5B0%5D=eng
SOLR
_version_ 1792347801276907523
author Ooi, Poh Hwa, Hager, Amber, Mazurak, Vera C., Dajani, Khaled, Bhargava, Ravi, Gilmour, Susan M., Mager, Diana R.
author_facet Ooi, Poh Hwa, Hager, Amber, Mazurak, Vera C., Dajani, Khaled, Bhargava, Ravi, Gilmour, Susan M., Mager, Diana R., Ooi, Poh Hwa, Hager, Amber, Mazurak, Vera C., Dajani, Khaled, Bhargava, Ravi, Gilmour, Susan M., Mager, Diana R.
author_sort ooi, poh hwa
container_issue 9
container_start_page 1422
container_title Liver Transplantation
container_volume 25
description <jats:p>Malnutrition is a common complication in patients with end‐stage liver disease (ESLD) awaiting liver transplantation (LT). Malnutrition and sarcopenia overlap in etiology and outcomes, with sarcopenia being defined as reduced skeletal muscle mass and muscle function. The purpose of this review was to identify the prevalence of sarcopenia with and without obesity in adults and children with ESLD and to assess the methodological considerations in sarcopenia diagnosis and the association of sarcopenia with pre‐ and post‐LT outcomes. A total of 38 articles (35 adult and 3 pediatric articles) retrieved from PubMed or Web of Science databases were included. In adults, the prevalence rates of pre‐LT sarcopenia, pre‐LT sarcopenic obesity (SO), post‐LT sarcopenia, and post‐LT SO were 14%‐78%, 2%‐42%, 30%‐100%, and 88%, respectively. Only 2 adult studies assessed muscle function in patients diagnosed with sarcopenia. The presence of pre‐LT sarcopenia is associated with higher wait‐list mortality, greater postoperative mortality, higher infection risk and postoperative complications, longer intensive care unit (ICU) stay, and ventilator dependency. The emerging pediatric data suggest that sarcopenia is prevalent in pre‐ and post‐LT periods. In 1 pediatric study, sarcopenia was associated with poor growth, longer perioperative length of stay (total/ICU) and ventilator dependency, and increased rehospitalization in children after LT. In conclusion, there is a high prevalence of sarcopenia in adults and children with ESLD. Sarcopenia is associated with adverse clinical outcomes. The present review is limited by heterogeneity in the definition of sarcopenia and in the methodological approaches in assessing sarcopenia. Future studies are needed to standardize the sarcopenia diagnosis and muscle function assessment, particularly in the pediatric population, to enable early identification and treatment of sarcopenia in adults and children with ESLD.</jats:p>
doi_str_mv 10.1002/lt.25591
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9sdC4yNTU5MQ
imprint Ovid Technologies (Wolters Kluwer Health), 2019
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2019
institution DE-14, DE-105, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1
issn 1527-6473, 1527-6465
issn_str_mv 1527-6473, 1527-6465
language English
last_indexed 2024-03-01T18:01:00.455Z
match_str ooi2019sarcopeniainchronicliverdiseaseimpactonoutcomes
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
physical 1422-1438
publishDate 2019
publishDateSort 2019
publisher Ovid Technologies (Wolters Kluwer Health)
record_format ai
recordtype ai
series Liver Transplantation
source_id 49
spelling Ooi, Poh Hwa Hager, Amber Mazurak, Vera C. Dajani, Khaled Bhargava, Ravi Gilmour, Susan M. Mager, Diana R. 1527-6465 1527-6473 Ovid Technologies (Wolters Kluwer Health) Transplantation Hepatology Surgery http://dx.doi.org/10.1002/lt.25591 <jats:p>Malnutrition is a common complication in patients with end‐stage liver disease (ESLD) awaiting liver transplantation (LT). Malnutrition and sarcopenia overlap in etiology and outcomes, with sarcopenia being defined as reduced skeletal muscle mass and muscle function. The purpose of this review was to identify the prevalence of sarcopenia with and without obesity in adults and children with ESLD and to assess the methodological considerations in sarcopenia diagnosis and the association of sarcopenia with pre‐ and post‐LT outcomes. A total of 38 articles (35 adult and 3 pediatric articles) retrieved from PubMed or Web of Science databases were included. In adults, the prevalence rates of pre‐LT sarcopenia, pre‐LT sarcopenic obesity (SO), post‐LT sarcopenia, and post‐LT SO were 14%‐78%, 2%‐42%, 30%‐100%, and 88%, respectively. Only 2 adult studies assessed muscle function in patients diagnosed with sarcopenia. The presence of pre‐LT sarcopenia is associated with higher wait‐list mortality, greater postoperative mortality, higher infection risk and postoperative complications, longer intensive care unit (ICU) stay, and ventilator dependency. The emerging pediatric data suggest that sarcopenia is prevalent in pre‐ and post‐LT periods. In 1 pediatric study, sarcopenia was associated with poor growth, longer perioperative length of stay (total/ICU) and ventilator dependency, and increased rehospitalization in children after LT. In conclusion, there is a high prevalence of sarcopenia in adults and children with ESLD. Sarcopenia is associated with adverse clinical outcomes. The present review is limited by heterogeneity in the definition of sarcopenia and in the methodological approaches in assessing sarcopenia. Future studies are needed to standardize the sarcopenia diagnosis and muscle function assessment, particularly in the pediatric population, to enable early identification and treatment of sarcopenia in adults and children with ESLD.</jats:p> Sarcopenia in Chronic Liver Disease: Impact on Outcomes Liver Transplantation
spellingShingle Ooi, Poh Hwa, Hager, Amber, Mazurak, Vera C., Dajani, Khaled, Bhargava, Ravi, Gilmour, Susan M., Mager, Diana R., Liver Transplantation, Sarcopenia in Chronic Liver Disease: Impact on Outcomes, Transplantation, Hepatology, Surgery
title Sarcopenia in Chronic Liver Disease: Impact on Outcomes
title_full Sarcopenia in Chronic Liver Disease: Impact on Outcomes
title_fullStr Sarcopenia in Chronic Liver Disease: Impact on Outcomes
title_full_unstemmed Sarcopenia in Chronic Liver Disease: Impact on Outcomes
title_short Sarcopenia in Chronic Liver Disease: Impact on Outcomes
title_sort sarcopenia in chronic liver disease: impact on outcomes
title_unstemmed Sarcopenia in Chronic Liver Disease: Impact on Outcomes
topic Transplantation, Hepatology, Surgery
url http://dx.doi.org/10.1002/lt.25591